| 44628-6 | Reason specimen size cannot be determined in Breast tumor |
| 44629-4 | Specimen size.maximum dimension in Breast tumor |
| 44630-2 | Specimen size additional dimension 1 in Breast tumor |
| 44631-0 | Specimen size additional dimension 2 in Breast tumor |
| 44634-4 | Reason invasive component size cannot be determined in Breast tumor Narrative |
| 44635-1 | Invasive component size.maximum dimension in Breast tumor |
| 44636-9 | Invasive component size additional dimension 1 in Breast tumor |
| 44637-7 | Invasive component size additional dimension 2 in Breast tumor |
| 44638-5 | Histologic type in Breast tumor |
| 44644-3 | Tubule formation in Breast tumor (qualitative, cap cancer protocols) |
| 44645-0 | Nuclear pleomorphism in Breast tumor (nottingham) |
| 44646-8 | Nottingham mitotic count.25x obj in Breast tumor (cap cancer protocols) |
| 44647-6 | Nottingham mitotic count.40x obj in Breast tumor (cap cancer protocols) |
| 44649-2 | Grading system in Breast tumor |
| 44650-0 | Mitotic count per 10 HPF in Breast tumor |
| 44663-3 | T classification in Breast tumor (cap cancer protocols) |
| 44666-6 | M stage of distant metastasis in Breast tumor Qualitative (qualitative, cap cancer protocols) |
| 44667-4 | Site of distant metastasis in Breast tumor |
| 44669-0 | Margin involvement in Breast tumor |
| 44672-4 | Invasive carcinoma uninvolved margin distance closest in Breast tumor |
| 44673-2 | DCIS.uninvolved margin distance.closest in Breast tumor |
| 44674-0 | Invasive carcinoma uninvolved margin closest in Breast tumor |
| 44675-7 | DCIS.uninvolved margin.closest in Breast tumor |
| 44676-5 | Margin(s) involved (invasive carcinoma in breast tumor) |
| 44677-3 | Margin(s) involved (dcis in breast tumor) |
| 44692-2 | Microcalcifications in Breast tumor |